Evidence map›Paper›PMID 41245470›Full record

ArticleNew microbes and new infections2025

Molecular detection of

Miguel Angel Aguilar-Luis, Wilmer Silva-Caso, Angela Cornejo-Tapia, Erico Cieza-Mora, Pablo Weilg, Carlos Bada, Olguita Del Aguila, Juana Del Valle-Mendoza

Abstract read
In one paragraph

Article in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miguel Angel Aguilar-LuisBiomedicine Laboratory, Research and Innovation Centre of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, 15087, Lima, Peru.
Wilmer Silva-CasoBiomedicine Laboratory, Research and Innovation Centre of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, 15087, Lima, Peru.
Angela Cornejo-TapiaBiomedicine Laboratory, Research and Innovation Centre of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, 15087, Lima, Peru.
Erico Cieza-MoraServicio de Pediatría. Hospital Regional de Salud de Cajamarca, Peru.
Pablo WeilgBiomedicine Laboratory, Research and Innovation Centre of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, 15087, Lima, Peru.
Carlos BadaServicio de Pediatría. Hospital de Emergencias Pediátricas, Lima, Peru.
Olguita Del AguilaServicio de Pediatría. Hospital Edgardo Rebagliati Martins, Lima, Peru.
Juana Del Valle-MendozaBiomedicine Laboratory, Research and Innovation Centre of the Faculty of Health Sciences, Universidad Peruana de Ciencias Aplicadas, 15087, Lima, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Community-acquired pneumonia (CAP) is one of the most common causes of morbidity and mortality among children under five worldwide. Objectives: To estimate the molecular prevalence of Hib and NTHi and identify associated clinical/epidemiological factors among infants (<1 year) hospitalized with CAP in Peru during 2010-2012, providing an early post-introduction baseline to inform long-term trends. Results: Among 339 infants, Conclusion: These findings do not represent the current epidemiology; rather, they delineate an early post-introduction baseline for Hib/NTHi in Peruvian infants with CAP. Our findings contribute to the timeline of

Indexed as

CAPCommunity-acquired pneumoniaHaemophilus influenzaeHibInfantsNTHiPCRPeru

Identifiers

PMID41245470
PMCPMC12617793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.